GMP Factory Supply API Gatifloxacin Sesquihydrate CAS No: 180200-66-2

Gatifloxacin sesquihydrate (180200-66-2) is a new antibiotics developed by fluoroquinolone broad-spectrum antibiotics in recent years. Gatifloxacin (180200-66-2) is the third generation of fluoroquinolone antibacterial drugs, which is a renewal of cyclopropoxia, hydrazine, and left-voxelofloxacin. Gatifloxacin (180200-66-2) is a new antibiotics developed by fluoroquinolone broad-spectrum antibiotics in recent years. Widely used in various infections such as respiratory, urethra.


Gatifloxacin is the fourth generation of fluoroquinolones, this product through the inhibition of bacterial DNA gyrase activity to exert antibacterial effect.
Product Feature
1 Antibacterial spectrum:In addition to the gram negative bacteria and gram positive bacteria have a strong antibacterial activity, the anaerobic bacteria, bacteria, mycoplasma, chlamydia and Mycobacterium, also have a good antibacterial effect.
2 Blood drug concentration is high, widely distributed in the body, with a long half-life, absolute bioavailability, strong bactericidal power.
3 Anti infection index is the highest in the quinolones have been listed
4 Stable chemical properties, small toxic side effect, not easy to produce drug resistance